Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus

The long-term control strategy of SARS-CoV-2 and other major respiratory viruses needs to include antivirals to treat acute infections, in addition to the judicious use of effective vaccines. Whilst COVID-19 vaccines are being rolled out for mass vaccination, the modest number of antivirals in use o...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Sarah Al-Beltagi, Cristian Alexandru Preda, Leah V. Goulding, Joe James, Juan Pu, Paul Skinner, Zhimin Jiang, Belinda Lei Wang, Jiayun Yang, Ashley C. Banyard, Kenneth H. Mellits, Pavel Gershkovich, Christopher J. Hayes, Jonathan Nguyen-Van-Tam, Ian H. Brown, Jinhua Liu, Kin-Chow Chang
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	MDPI AG 2021-02-01
سلاسل:	Viruses
الموضوعات:	thapsigargin inhibitor antiviral SARS-CoV-2 coronavirus OC43 respiratory syncytial virus
الوصول للمادة أونلاين:	https://www.mdpi.com/1999-4915/13/2/234
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!